Dietary Additives and Supplements Revisited: the Fewer, the Safer for Gut and Liver Health
- 10 June 2019
- journal article
- research article
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 5 (4) , 303-316
Abstract
Purpose of Review The supplementation of dietary additives into processed foods has exponentially increased in the past few decades. Similarly, the incidence rates of various diseases, including metabolic syndrome, gut dysbiosis, and hepatocarcinogenesis, have been elevating. Current research reveals that there is a positive association between food additives and these pathophysiological diseases. This review highlights the research published within the past 5 years that elucidate and update the effects of dietary supplements on liver and intestinal health. Recent Findings Some of the key findings include: enterocyte dysfunction of fructose clearance causes non-alcoholic fatty liver disease (NAFLD); non-caloric sweeteners are hepatotoxic; dietary emulsifiers instigate gut dysbiosis and hepatocarcinogenesis; and certain prebiotics can induce cholestatic hepatocellular carcinoma (HCC) in gut dysbiotic mice. Overall, multiple reports suggest that the administration of purified, dietary supplements could cause functional damage to both the liver and gut. Summary The extraction of bioactive components from natural resources was considered a brilliant method to modulate human health. However, current research highlights that such purified components may negatively affect individuals with microbiotal dysbiosis, resulting in a deeper break of the symbiotic relationship between the host and gut microbiota, which can lead to repercussions on gut and liver health. Therefore, ingestion of these dietary additives should not go without some caution!Keywords
Funding Information
- Foundation for the National Institutes of Health (CA219144)
This publication has 175 references indexed in Scilit:
- Altered profile of human gut microbiome is associated with cirrhosis and its complicationsJournal of Hepatology, 2014
- Development of Hepatocellular Carcinoma in a Murine Model of Nonalcoholic Steatohepatitis Induced by Use of a High-Fat/Fructose Diet and Sedentary LifestyleThe American Journal of Pathology, 2014
- Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trialEuropean Journal of Nutrition, 2014
- Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in MicePLOS ONE, 2014
- Prediagnostic Levels of Serum One-Carbon Metabolites and Risk of Hepatocellular CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2013
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretomeNature, 2013
- Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver AxisPLOS ONE, 2013
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosisJournal of Hepatology, 2013
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic SteatohepatitisDigestive Diseases and Sciences, 2011
- Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasiaJournal of Autoimmunity, 2008